Zellik Pharma SRL
4.4 FTEZellik Pharma reported total assets of €1.25m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Oct 2026), with 4.4 full-time equivalents.
By total assets for 2025, Zellik Pharma ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Zellik Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -5 % Total assets +6 % Headcount (avg FTE) -49 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zellik Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Oct 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
Zellik Pharma's financial analysis
- Solvency35.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zellik Pharma
Zellik Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0881.910.538
- VAT number
- BE0881910538
- Peppol
- Registered · 0208:0881910538 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Jun 2006
- Registered office
- 1731 Asse
- Size
- Micro · 4.4 FTE
- Latest accounts
- 2025 · filed on 23 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Zellik Pharma (SRL) has been based in Asse since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 389 € and equity of 442,955 €; its revenue is not published. With 4.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.4%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Zellik Pharma
Companies in the same business, of comparable size and area, outside its group.
- Niemegeers-Engels BV Retail sale of pharmaceutical products Asse · balance sheet €1.23m
- Pharmacie du Gros Fayt Retail sale of pharmaceutical products Courcelles · balance sheet €1.25m
- Apotheek Leut Retail sale of pharmaceutical products Maasmechelen · balance sheet €1.25m
- Groenenhoek Retail sale of pharmaceutical products Antwerp · balance sheet €1.25m
- Apoteek Rigaux Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet €1.25m
- Bauphar Retail sale of pharmaceutical products Rebecq · balance sheet €1.24m
- Oostveld - Pharma Retail sale of pharmaceutical products Lievegem · balance sheet €1.26m
- Angophar Retail sale of pharmaceutical products Brussels · balance sheet €1.26m
Frequently asked questions about Zellik Pharma
What is the revenue of Zellik Pharma?
Zellik Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Zellik Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0881910538 for Zellik Pharma, if the company is VAT-registered. Its company number (CBE) is 0881.910.538.
Where is the registered office of Zellik Pharma?
According to the CBE register, the registered office of Zellik Pharma is in 1731 Asse.
What is the equity of Zellik Pharma?
At the close of the 2025 financial year, the equity of Zellik Pharma amounts to 442,955 €, a solvency of 35.4% of total assets.
How many people work at Zellik Pharma?
4.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Zellik Pharma?
The register lists 2 active mandates at Zellik Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Zellik Pharma within its sector?
By total assets for 2025, Zellik Pharma ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Zellik Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →